Emmaus Life Sciences, Inc.
Emmaus Life Sciences, Inc., a leading biopharmaceutical company headquartered in the United States, is dedicated to developing innovative therapies for rare diseases. Founded in 2002, the company has made significant strides in the industry, particularly in the treatment of sickle cell disease.
Emmaus is renowned for its flagship product, Endari, which is the first FDA-approved treatment specifically for patients aged five and older with this condition. The unique formulation of L-glutamine in Endari helps reduce the frequency of painful crises and hospitalisations, setting it apart in the market.
With a strong commitment to research and development, Emmaus Life Sciences continues to expand its operational reach, aiming to improve the quality of life for patients globally. The company’s dedication to addressing unmet medical needs positions it as a notable player in the biopharmaceutical landscape.
-20 vs industry average
Emmaus Life Sciences, Inc.’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Emmaus Life Sciences, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Emmaus Life Sciences, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Emmaus Life Sciences, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Emmaus Life Sciences, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Emmaus Life Sciences, Inc.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project